1. Home
  2. WVE vs CASH Comparison

WVE vs CASH Comparison

Compare WVE & CASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Wave Life Sciences Ltd.

WVE

Wave Life Sciences Ltd.

HOLD

Current Price

$7.25

Market Cap

2.4B

Sector

Health Care

ML Signal

HOLD

Logo Pathward Financial Inc.

CASH

Pathward Financial Inc.

HOLD

Current Price

$87.48

Market Cap

2.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
WVE
CASH
Founded
2012
1954
Country
Singapore
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
2.4B
2.0B
IPO Year
2015
1996

Fundamental Metrics

Financial Performance
Metric
WVE
CASH
Price
$7.25
$87.48
Analyst Decision
Strong Buy
Buy
Analyst Count
16
2
Target Price
$29.50
$107.50
AVG Volume (30 Days)
6.4M
155.7K
Earning Date
04-28-2026
04-22-2026
Dividend Yield
N/A
0.20%
EPS Growth
N/A
18.88
EPS
N/A
1.57
Revenue
$3,704,000.00
$839,894,000.00
Revenue This Year
N/A
$7.56
Revenue Next Year
$85.67
$6.02
P/E Ratio
N/A
$62.85
Revenue Growth
149.43
11.29
52 Week Low
$5.02
$65.93
52 Week High
$21.73
$101.26

Technical Indicators

Market Signals
Indicator
WVE
CASH
Relative Strength Index (RSI) 34.60 36.77
Support Level $6.93 $87.19
Resistance Level $7.67 $94.84
Average True Range (ATR) 0.33 2.88
MACD 0.23 -0.29
Stochastic Oscillator 47.80 20.53

Price Performance

Historical Comparison
WVE
CASH

About WVE Wave Life Sciences Ltd.

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.

About CASH Pathward Financial Inc.

Pathward Financial Inc is a unitary savings and loan holding company. It's a wholly owned full-service banking subsidiary of Meta Financial, is both a community-oriented financial institution offering a variety of financial services to meet the needs of the communities it serves, and a payments company providing services on a nationwide basis. It operates through three reportable segments: Consumer: The Consumer segment includes the Partner Solutions business line, which collaborates with partners to navigate payment and lending needs; Commercial: The Commercial segment includes the Company's Commercial Finance business line, which helps businesses access funds needed to launch, operate, and grow; and Corporate Services. The majority of the revenue is generated from Consumer segment.

Share on Social Networks: